Share

Related Stories

  • A hormone that fights fat with fat
    Sanford-Burnham scientists reveal that a hormone called orexin prevents obesity in mice by activating brown fat, a tissue that’s good at burning calories.
  • Catching up on Circulating Tumor Cell Technology
    Circulating tumor cells (CTCs) are cells that ‘escape’ from primary tumor cells and migrate into the bloodstream, where they circulate through the body. CTCs were first identified in the 1980s as cells that had the morphology of tumor cells but were found in the blood. Over the past two decades technological innovations have eased the detection and analysis of CTCs. The resulting investigations of CTCs are an important area of clinical research because they are demonstrating that CTCs have potential clinical value as warning signals of cancer progression.
  • Senectus Therapeutics and AstraZeneca Collaborate to Identify Triggers to Cell Aging
    Senectus Therapeutics has signed a deal to screen a selection of AstraZeneca’s chemical compound library to identify those which trigger a key element of cancer cell ageing – called senescence. Senescent cells are those which after many rounds of cell growth and division enter a ‘sleep’ phase where the normal cell cycle is stopped. This blocks the uncontrolled growth and division of cells. It is a natural mechanism to prevent cancer. But cancer cells find ways to trick their way past this block and continue to grow and divide. Understanding the triggers to cell ageing may reveal molecular targets for completely new ways to treat cancer.
  • ‘Blindfold handshake’ in the cell prevents diseases
    Researchers have uncovered how cells ensure inheritance of their genetic information in order to prevent diseases.
  • FDA approves new treatment for chronic lymphocytic leukaemia
    The U.S. Food and Drug Administration has approved Arzerra (ofatumumab) for patients with chronic lymphocytic leukaemia, a slowly progressing cancer of the blood and bone marrow.

Top 5 Stories

News

Mitotic spindles give cancer clues

12 February 2010

Scientists working at the University of Dundee have discovered a form of stem cell activity that might help lead to the early identification of cancer.

The new research reveals differences between the way stem cells behave in normal tissue and their activity in tissue that is pre-cancerous.

The research team, led by Professor Inke Näthke and funded by the Bobby Moore Fund for Cancer Research UK, examined the behaviour of mitotic spindles – structures that separate genetic material during the key process of cell division.

Using state-of-the-art imaging techniques, they generated three-dimensional pictures of mitotic spindles in intestinal tissue. They found the spindles behaved differently in normal, healthy tissue and in tissue with a single mutation associated with bowel (colorectal) cancer.

‘The process we were investigating is called asymmetric cell division,’ said Professor Näthke, a Principal Investigator in the Dundee Cancer Centre. ‘The importance of asymmetric divisions for stem cell function and maintenance is well established in the developing nervous system and the skin. However, its role in gut tissue and its role in helping to produce tumours are still debated.

‘We developed an imaging technique that permits the visualization of three-dimensional aspects of tissue architecture to identify differences in stem and non-stem cells in the intestinal tract. Using this technique, we found that this process of asymmetric division in stem cells is lost in tissue that gives rise to cancers in the gut, so these spindles behave differently in pre-cancerous tissue.

‘In the healthy tissue this process works well. In the precancerous tissue it seems to be compromised, which is an important sign, as this tissue otherwise appears normal.

‘This is important as it may have implications in developing techniques for identifying pre-cancerous tissue at an early stage, when it still appears normal, giving clinicians a chance to catch the disease in the early stages of development. It might also have implications for the types of treatment that should be considered.’

 

This article is featured in:
Target Identification/ Validation

 

Comment on this article

You must be registered and logged in to leave a comment about this article.